索拉非尼治疗巨块型肝癌获部分缓解并长期生存1例
被引量：1
摘要
1病案摘要患者男性,62岁。2006年8月8日因＂上腹饱胀不适伴纳差乏力、消瘦3月余＂就诊于安徽医科大学第一附属医院,门诊B超示：肝右叶16cm×14.8cm巨大占位,门静脉受压显示不清,考虑巨块型肝癌。患者1994年经检查发现乙肝病,
出处
《临床肿瘤学杂志》
CAS
2012年第7期665-666,共2页
Chinese Clinical Oncology
基金
安徽省2009年度科研计划资助项目(09020303042)
参考文献5
-
1Vincnzi B, Santini D, Russo A, tt al. Early skin toxicity as a predictive factor for tumor control in hcpalocellular carcinmta pa- tients treated with sorafenib [ J ]. Oncologist, 2010,15 ( 1 ) : 85 -92.
-
2Kim RD, Bvrne MT, Hmnmel J, et al. Association of hyperten- sion with overall outcome in patients taking sorafenib in advanced hepalocellular carcinoma [ J ]. J Clin Oneol, 2010, 28 (Suppl) : a14536.
-
3l,lowt JM, Ricci S, Mazzaferro V, el al. Sorafimib iv, advanced hpatocellular carcinoma[ J ]. N Engl J Med, 2008, 359(2) :378 - 390.
-
4Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced ch'ar-e renal-ceil carcinoma [ J ]. N Engl J Med, 2007, 356 (2) :125 -134.
-
5Schmidinger M, Zielinski CC, Vogl UM, eta. Cardiac tnxicily of snnitinib and sorafenib in patients with metastatic renal eell carcinoma[ J ]. J Clin Oncol, 2008, 26 ( 32 ) :5204 - 5212.
同被引文献8
-
1Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma [ J ]. N Engl J Med, 2007,356 (2) :125-134.
-
2Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sor- afenib in patients in the Asia-Pacific region with advanced hepato- cellular carcinoma: a phase Ill randomized, double-blind, place- bo-controlled trial [ J]. Lancet Oncol, 2009,10 ( 1 ) :25-34.
-
3Strumberg D, Awada A, Hirte H, et al. Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid turnouts: Is rash associated with treatment outcome? [ J]. Eur J Cancer, 2006,42(4) :548-556.
-
4Porta C, Paglino C, Imarisio I, et al. Uncovering Pandora' s vase : the growing problem of new toxicities fromnovel anticancer a- gents EJI. Clin Exp Med, 2007, 7(4) :127-134.
-
5Kim RD, Byrne MT, Hammel J, et al. Association of hyperten- sion with overall outcome in patients taking sorafenib in advanced hepatoeellular carcinoma [ EB/OL ]. ( 2010-05-20 ) [ 2013-02- 01 ]. http://meeting, ascopubs, org/cgi/content/abstract/28/15_ suppl/e145367 sid = d3288d93-fec4-4bbd-a156-66fc07575b05.
-
6Vincenzi B, Santini D, Russo A, et al. Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma pa- tients treated with sorafenib [ J]. Oncologist, 2010,15 ( 1 ) : 85- 92.
-
7Schmidinger M, Zielinski CC, Vogl UM, et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carci- noma [J]. J Clin Oncol, 2008,26(32) :5204.
-
8Josep ML, Serglo R, Vincenzo M, et al. Sorafenib in Advanced Hepatocellular Carcinoma [ J ]. N Engl J Med, 2008,359 ( 2 ) : 378 -390.
-
1汤连喜,陈晓林,孙刚.巨块型肝癌的介入治疗[J].中国冶金工业医学杂志,2002,19(5):307-308.
-
2李明主,李定跃,李明,汪雪源,陈明良,王云良,李元洪,王金波,蒋存兵,胡义辉.以手术为主的综合治疗巨块型肝癌的体会[J].中华外科杂志,2002,40(8):584-584.
-
3李元,谢春明,冯对平,杨敏玲,庞宁东,陈毅.肝动脉化疗栓塞联合微波消融治疗巨块型肝癌疗效观察[J].中国药物经济学,2014,9(6):84-86. 被引量：4
-
4贾欣维,贾香丽.巨块型肝癌—肝动脉灌注药物化疗1例报告[J].临床荟萃,1995,10(22):1053-1053.
-
5线治中.拟定“四步曲”方案治疗巨块型肝癌疗效观察[J].医学动态,1997(1):12-14.
-
6冯学胜.肿瘤坏死因子与肝病[J].国外医学（消化系疾病分册）,1994,14(4):207-209. 被引量：6
-
7李桂芳,孙海,骆益宙,翟群,雷芳,谢松柏,李子贺.肝动脉化疗栓塞联合瘤内无水酒精注射治疗巨块型肝癌的临床研究[J].海南医学,1999,10(6):110-112.
-
8刘志坚,王国祥,贾文辉,董玉红.肝动脉化疗栓塞加无水酒精注射治疗巨块型肝癌17例报告[J].宁夏医学院学报,1998,20(3):34-35.
-
9赵卫林,乔钦才,张永红,郭全合,乔钦增.香菇多糖联合化疗药物瘤内注射治疗巨块型肝癌临床分析[J].中国误诊学杂志,2008,8(23):5572-5573. 被引量：4
-
10陈伟,李菡,张志红.白介素-2、顺铂治疗恶性胸腔积液的疗效[J].临床肺科杂志,2016,21(3):518-521. 被引量：3
